Avalo Therapeutics (AVTX) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Avalo Therapeutics (AVTX) over the last 11 years, with Q3 2025 value amounting to 0.0.
- Avalo Therapeutics' Asset Utilization Ratio fell 8076.45% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 8076.45%. This contributed to the annual value of 0.01 for FY2024, which is 9274.43% down from last year.
- Latest data reveals that Avalo Therapeutics reported Asset Utilization Ratio of 0.0 as of Q3 2025, which was down 8076.45% from 0.0 recorded in Q2 2025.
- Avalo Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.56 during Q2 2023, with a 5-year trough of 0.0 in Q3 2025.
- In the last 5 years, Avalo Therapeutics' Asset Utilization Ratio had a median value of 0.08 in 2022 and averaged 0.15.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 73991.44% in 2022, then tumbled by 9876.02% in 2024.
- Avalo Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.06 in 2021, then skyrocketed by 739.91% to 0.52 in 2022, then tumbled by 85.17% to 0.08 in 2023, then tumbled by 95.38% to 0.0 in 2024, then plummeted by 56.89% to 0.0 in 2025.
- Its last three reported values are 0.0 in Q3 2025, 0.0 for Q2 2025, and 0.0 during Q1 2025.